Article

Segment 10: The Important Distinction Between Diagnostic, Screening Tests

There is an important distinction between diagnostic and screening tests, and they have different issues in regards to decision making-although the person making treatment decisions should ultimately be guiding the ship, according to Bryan Loy, MD, MBA.

There is an important distinction between diagnostic and screening tests, and they have different issues in regards to decision making—although the person making treatment decisions should ultimately be guiding the ship, according to Bryan Loy, MD, MBA.

He added that he’s always surprised to learn the lack of medical history that is taken, for example, in conjunction with a BRCA1 or BRCA2 test.

“It feels like we’ve still got a long way to go in creating some accountability and a measurement system and education system to get people ordering them thoughtfully,” Dr Loy said.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
Constance Blunt, MD, medical oncologist, Mary Bird Perkins Cancer Center
Coral Omene, MD, PhD, sitting for a vieo interview
David Awad, PharmD, BCOP
Screenshot of Coral Omene, MD, PhD
ASCO 2025
Constance Blunt, MD, medical oncologist, Mary Bird Perkins Cancer Center
Cathy Eng, MD, FACP, FASCO
Nini Wu, MD, Navista
Eileen Peng, PharmD, sitting for a video interview
Nini Wu, MD, Navista
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo